Proliferation index as a predictor of prognosis in malignant gliomas of childhood

Cancer

Volumn 79, Issue 4, 1997, Pages 849-856

  Pollack, Ian F ^a   Campbell, Jeffrey W ^a   Hamilton, Ronald L ^b   Martinez, A Julio ^b   Bozik, Michael E ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

anaplastic astrocytoma; childhood; glioblastoma; MIB 1; prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; HYDROXYUREA; LOMUSTINE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY KI 67; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ARTICLE; BRAIN CANCER; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MULTIMODALITY CANCER THERAPY; NEUROPATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CELL DIVISION; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KI-67 ANTIGEN; MALE; PROGNOSIS;

EID: 0031039479     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970215)79:4<849::AID-CNCR23>3.0.CO;2-Z     Document Type: Article

References (32)

1. Pollack IF. Current concepts: brain tumors in children. N Engl J Med 1994; 331:1500-7.
2. Young JL, Miller RW. Incidence of malignant tumors in U.S. children. J Pediatr 1975; 86:254-8.
3. Campbell J, Pollack IF, Shultz BL, Martinez AJ. Prognostic factors in the management of pediatric malignant gliomas. Neurosurgery 1996; 38:258-64.
4. Sposto R, Ertel IJ, Jenkin RDT, Boesel CP, Venes JL, Ortega JA, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. J Neurooncol 1989; 7:165-77.
5. Artico M, Cervoni L, Celli P, Salvati M, Palma L. Supratentorial glioblastoma in children: a series of 27 surgically treated cases. Childs Nerv Syst 1993; 9:7-9.
6. Dohrman GJ, Farwell JR, Flannery JT. Glioblastoma multiforme in children. J Neurosurg 1976; 44:442-8.
7. Dropcho E, Wisoff J, Walker R, Allen JC. Supratentorial malignant gliomas in childhood: a review of fifty cases. Ann Neural 1978; 22:355-64.
8. Phuphanich S, Edwards MSB, Levin VA, Vestnys PS, Wara WM, Davis RL, et al. Supratentorial malignant gliomas of childhood: results of treatment with radiation therapy and chemotherapy. J Neurosurg 1984; 60:495-9.
9. Seaward S, Goldwein J, Needle M, Sutton LN, Phillips P, Rorke L, et al. Malignant gliomas in children: patterns of presentation, treatment and prognostic factors [abstract]. Pediatr Neurosurg 1994; 21:156-7.
10. Wisoff JH, Boyett J, Brandt K, Finlay JL, Berger MS. Neurosurgical management and influence of extent of resection on survival in pediatric high-grade astrocytomas: a report on CCG 945 [abstract] J Neurosurg 1993; 78:344A.
11. Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. J Clin Oncol 1995; 13:112-23.
12. Duffner PK, Krischer JP, Burger PC, Cohen ME, Backstrom JW, Horowitz ME, et al. Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience. J Neurooncol 1996; 28:245-56.
13. Hoshino T, Rodriguez LA, Cho KG, Lee KS, Wilson CB, Edwards MSB, et al. Prognostic implications of the proliferative potential of low-grade astrocytomas. J Neurosurg 1988; 69:839-42.
14. Zuber P, Hamou M-F, deTribolet N. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery 1988; 22:364-8.
15. Germano IM, Ito M, Cho KG, Hoshino T, Davis RL, Wilson CB. Correlation of histopathological features and proliferative potential of gliomas. J Neurosurg 1989; 70:701-6.
16. Labrousse F, Daumas-Duport C, Batorski L, Hoshino T. Histological grading and bromodeoxyuridine labeling index of astrocytomas. J Neurosurg 1991; 75:202-5.
17. Jaros E, Perry RH, Adam L, Kelly PJ, Crawford PJ, Kalbag RM, et al. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumors. Br J Cancer 1992; 66:373-85.
18. Prados MD, Krouwer HGJ, Edwards MSB, Cogen PH, Davis RL, Hoshino T. Proliferative potential and outcome in pediatric astrocytic tumors. J Neurooncol 1992; 13:277-82.
19. Hopf NJ, Bremm J, Bohl J, Perneczky A. Image analysis of proliferating cells in tumors of the human nervous system: an immunohistological study with the monoclonal antibody Ki-67. Neurosurgery 1994; 35:917-23.
20. Sallinen PK, Haapasalo HK, Visakorpi T, Helen PT, Rantala IS, Isola JJ, et al. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 1994; 174:275-82.
21. Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133:1710-5.
22. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 1994; 74:1921-6.
23. Pendergrass TW, Milstein JM, Geyer JR, Mulne AF, Kosnik EJ, Morris JD, et al. Eight drugs in one day chemotherapy for brain tumors: experience with 107 children and rationale for preradiation chemotherapy. J Clin Oncol 1987; 5:1221-31.
24. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. In: Sobin LH, editor. International histological classification of tumours. Vol 21. 2nd edition. Geneva:Springer-Verlag, 1993:11-30.
25. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39:741-8.
26. Hsu S, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 1981; 29:577-80.
27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
28. Mantel NW. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-70.
29. Russell DS, Rubinstein LJ. Pathology of tumours of the nervous system. 5th edition. Baltimore:Williams and Wilkins, 1989:105-11.
30. Papahill PA, Ramsay DA, Del Maestro RF. Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning efficacy of resection and the significance of necrosis. Neurosurgery 1996; 38:822-9.
31. The Childhood Brain Tumor Consortium. Intraobserver reproducibility in assigning brain tumors to classes in the World Health Organization diagnostic scheme. J Neurooncol 1989; 7:211-24.
32. Sobel EL, Gilles FH, Leviton A, Tavare CJ, Hedley-White ET, Rorke LB, et al. Survival of children with infratentorial neuroglial tumors. Neurosurgery 1996; 39:45-56.